Loading…
Sectoral / Thematic · HDFC Mutual Fund · AMFI code 152081HDFC Pharma and Healthcare Fund
Disclosed for 10 months, Jan 2026 to Oct 2026.Published as: HDFC Pharma and Healthcare Fund (An open-ended equity scheme investing in Pharma and Healthcare related companies)
Portfolio value
₹3,666 Cr
up ₹164 Cr vs Sep 2026
- Stocks held
- 38
- unchanged
- Top 10 weight
- 51.7%
- of the portfolio in its ten largest
- Cash & debt
- 1.2%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 22
Holdings as of the end of October 2026, from HDFC Mutual Fund’s monthly portfolio disclosure. Fund houses publish each month’s portfolio within 10 days of the month end, and this page is updated after they do. How the data is checked
HDFC Pharma and Healthcare Fund is an active equity fund in the Sectoral / Thematic category from HDFC Mutual Fund. In October 2026 it disclosed 38 stocks worth ₹3,666 Cr, up ₹164 Cr from Sep 2026. Its largest positions were Divi's Laboratories Limited (9.4%), Sun Pharmaceutical Industries Limited (7.7%), Dr. Reddy's Laboratories Limited (6.7%); the ten largest together made up 51.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.8% of its equity. Cash and debt stood at 1.2%. Compared with Sep 2026 the fund entered 1 new stock and exited 1.
Against 244 other Sectoral / Thematic funds
Concentration
61%
Top-10 weight is higher than 61% of peers
Breadth
36%
Holds more stocks than 36% of peers
Cash
19%
Holds more cash than 19% of peers
What these mean: concentration · cash
Holdings in October 2026
Download CSVEvery line the fund disclosed, with the change against Sep 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Divi's Laboratories Limited | 9.44% | up 0.05 pts | ₹346 Cr | up ₹17.3 Cr | Added |
| Sun Pharmaceutical Industries Limited | 7.74% | down 0.54 pts | ₹284 Cr | down ₹6.2 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 6.66% | up 3.47 pts | ₹244 Cr | up ₹132 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.19% | up 1.50 pts | ₹190 Cr | up ₹61.1 Cr | Added |
| Alkem Laboratories Limited | 4.75% | up 0.10 pts | ₹174 Cr | up ₹11.4 Cr | Added |
| Cipla Limited | 4.06% | down 0.09 pts | ₹149 Cr | up ₹3.6 Cr | Added |
| Acutaas Chemicals Limited | 3.70% | up 0.53 pts | ₹136 Cr | up ₹24.6 Cr | Added |
| Max Healthcare Institute Limited | 3.44% | down 0.17 pts | ₹126 Cr | down ₹30 L | Held |
| Aster DM Healthcare Limited | 3.37% | down 0.19 pts | ₹123 Cr | down ₹1.1 Cr | Trimmed |
| Lupin Limited | 3.35% | down 0.19 pts | ₹123 Cr | down ₹1.2 Cr | Trimmed |
| Torrent Pharmaceuticals Limited | 3.35% | down 0.30 pts | ₹123 Cr | down ₹5 Cr | Trimmed |
| Neuland Laboratories Limited | 2.96% | down 0.29 pts | ₹108 Cr | down ₹5.1 Cr | Trimmed |
| Shilpa Medicare Limited | 2.92% | down 0.31 pts | ₹107 Cr | down ₹6.1 Cr | Trimmed |
| Anthem Biosciences Limited | 2.92% | down 0.25 pts | ₹107 Cr | down ₹3.8 Cr | Trimmed |
| Rubicon Research Limited | 2.69% | up 0.18 pts | ₹98.8 Cr | up ₹10.6 Cr | Added |
| Global Health Limited | 2.52% | down 0.20 pts | ₹92.3 Cr | down ₹3 Cr | Trimmed |
| Paras Healthcare Limited | 2.34% | up 2.34 pts | ₹85.7 Cr | up ₹85.7 Cr | New |
| Glenmark Pharmaceuticals Limited | 1.96% | down 0.12 pts | ₹71.9 Cr | down ₹1.1 Cr | Trimmed |
| IPCA Laboratories Limited | 1.93% | down 1.05 pts | ₹70.7 Cr | down ₹33.7 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 1.92% | down 0.08 pts | ₹70.6 Cr | up ₹39 L | Added |
| Krishna Institute Of Medical Sciences Limited | 1.89% | down 0.21 pts | ₹69.1 Cr | down ₹4.4 Cr | Trimmed |
| Molbio Diagnostics Limited | 1.87% | down 0.14 pts | ₹68.5 Cr | down ₹1.9 Cr | Trimmed |
| Zydus Lifesciences Limited | 1.86% | up 0.04 pts | ₹68.4 Cr | up ₹4.6 Cr | Added |
| Sai Life Sciences Limited | 1.74% | up 0.16 pts | ₹63.8 Cr | up ₹8.6 Cr | Added |
| Jupiter Life Line Hospitals Limited | 1.66% | down 0.02 pts | ₹60.8 Cr | up ₹1.9 Cr | Added |
| Metropolis Healthcare Limited | 1.61% | down 0.06 pts | ₹59 Cr | up ₹43 L | Added |
| Wockhardt Limited | 1.47% | down 0.24 pts | ₹53.9 Cr | down ₹6.1 Cr | Trimmed |
| Symbiotec Pharmalab Limited | 1.38% | up 0.02 pts | ₹50.5 Cr | up ₹2.8 Cr | Added |
| Biocon Limited | 1.33% | down 0.14 pts | ₹48.9 Cr | down ₹2.6 Cr | Trimmed |
| Cash, TREPS & receivables | 1.22% | down 2.01 pts | ₹44.7 Cr | down ₹68.5 Cr | Trimmed |
| Gland Pharma Limited | 1.05% | down 0.73 pts | ₹38.6 Cr | down ₹23.8 Cr | Trimmed |
| Corona Remedies Limited | 1.02% | down 0.02 pts | ₹37.3 Cr | up ₹97 L | Added |
| Thyrocare Technologies Limited | 0.90% | down 0.20 pts | ₹32.8 Cr | down ₹5.6 Cr | Trimmed |
| Entero Healthcare Solutions Ltd | 0.89% | down 0.12 pts | ₹32.6 Cr | down ₹2.8 Cr | Trimmed |
| Eris Lifesciences Limited | 0.86% | down 0.07 pts | ₹31.4 Cr | down ₹96 L | Trimmed |
| Jubilant Pharmova Limited | 0.80% | down 0.13 pts | ₹29.3 Cr | down ₹3.3 Cr | Trimmed |
| Bajaj Healthcare Limited | 0.48% | down 0.06 pts | ₹17.4 Cr | down ₹1.2 Cr | Trimmed |
| Novartis India Limited | 0.46% | down 0.09 pts | ₹17 Cr | down ₹2.3 Cr | Trimmed |
| Laxmi Dental Limited | 0.31% | down 0.04 pts | ₹11.4 Cr | down ₹89 L | Trimmed |
What changed, Sep 2026 to Oct 2026
New New positions (1)
- Paras Healthcare Limited2.3% · ₹85.7 Cr
Exited Exited (1)
- Suven Pharmaceuticals Limitedwas 0.3% · ₹11.1 Cr
Added Biggest additions
- Dr. Reddy's Laboratories Limitedup ₹132 Cr (+3.47% pts)
- Apollo Hospitals Enterprise Limitedup ₹61.1 Cr (+1.50% pts)
- Acutaas Chemicals Limitedup ₹24.6 Cr (+0.53% pts)
- Divi's Laboratories Limitedup ₹17.3 Cr (+0.05% pts)
- Alkem Laboratories Limitedup ₹11.4 Cr (+0.10% pts)
- Rubicon Research Limitedup ₹10.6 Cr (+0.18% pts)
- Sai Life Sciences Limitedup ₹8.6 Cr (+0.16% pts)
- Zydus Lifesciences Limitedup ₹4.6 Cr (+0.04% pts)
- Cipla Limitedup ₹3.6 Cr (−0.09% pts)
- Symbiotec Pharmalab Limitedup ₹2.8 Cr (+0.02% pts)
Trimmed Biggest reductions
- IPCA Laboratories Limiteddown ₹33.7 Cr (−1.05% pts)
- Gland Pharma Limiteddown ₹23.8 Cr (−0.73% pts)
- Sun Pharmaceutical Industries Limiteddown ₹6.2 Cr (−0.54% pts)
- Wockhardt Limiteddown ₹6.1 Cr (−0.24% pts)
- Shilpa Medicare Limiteddown ₹6.1 Cr (−0.31% pts)
- Thyrocare Technologies Limiteddown ₹5.6 Cr (−0.20% pts)
- Neuland Laboratories Limiteddown ₹5.1 Cr (−0.29% pts)
- Torrent Pharmaceuticals Limiteddown ₹5 Cr (−0.30% pts)
- Krishna Institute Of Medical Sciences Limiteddown ₹4.4 Cr (−0.21% pts)
- Anthem Biosciences Limiteddown ₹3.8 Cr (−0.25% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2026, the weight rose most in Healthcare Services (+2.3 pts), and fell most in Pharmaceuticals & Biotechnology (−1.9 pts) and Healthcare Equipment & Supplies (−0.2 pts).
- Healthcare Services22.9% → 25.1%+2.3 pts
- Pharmaceuticals & Biotechnology73.6% → 71.8%−1.9 pts
- Healthcare Equipment & Supplies2.4% → 2.2%−0.2 pts
- Retailing1.0% → 0.9%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2026 | Jul 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.0% | 71.5% | 73.6% | 71.8% |
| Healthcare Services | 27.4% | 28.0% | 22.9% | 25.1% |
| Healthcare Equipment & Supplies | 0.6% | 0.5% | 2.4% | 2.2% |
| Retailing | — | — | 1.0% | 0.9% |
Allocation in Oct 2026change vs Sep 2026
- Pharmaceuticals & Biotechnology (25)71.8%▼ 1.9 pts
- Healthcare Services (10)25.1%▲ 2.3 pts
- Healthcare Equipment & Supplies (2)2.2%▼ 0.2 pts
- Retailing (1)0.9%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2026
1.2%
▼ 2.0 pts vs Sep 2026
- Cash alone
- 1.2%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.5% – 3.2%
- lowest to highest · record 3.2% in Sep 2026
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
All 10 months
| Month | Portfolio value | Stocks | Entered | Exited | Cash | Cash & debt | Turnover |
|---|---|---|---|---|---|---|---|
| Oct 2026 | ₹3,666 Cr | 38 | 1 | 1 | 1.2% | 1.2% | 32% |
| Sep 2026 | ₹3,501 Cr | 38 | 1 | 2 | 3.2% | 3.2% | 36% |
| Aug 2026 | ₹3,311 Cr | 39 | 2 | 0 | 1.6% | 1.6% | 35% |
| Jul 2026 | ₹2,940 Cr | 37 | 2 | 0 | 0.5% | 0.5% | 37% |
| Jun 2026 | ₹2,611 Cr | 35 | 4 | 1 | 2.8% | 2.8% | 42% |
| May 2026 | ₹2,362 Cr | 32 | 2 | 1 | 1.3% | 1.3% | 44% |
| Apr 2026 | ₹2,159 Cr | 31 | 3 | 1 | 2.7% | 2.7% | 43% |
| Mar 2026 | ₹1,977 Cr | 29 | 1 | 1 | 1.5% | 1.5% | 38% |
| Feb 2026 | ₹2,031 Cr | 29 | 0 | 0 | 1.8% | 1.8% | 39% |
| Jan 2026 | ₹1,876 Cr | 29 | 2.7% | 2.7% | 38% |